ATXI: Avenue Therapeutics O‘sish sur’atiga tuzatilgan narx-foyda

avenuetx.com (ATXI) brendining ramzi va logotipi

PEG ga asoslangan biznesning past baholanish omili Avenue Therapeutics (ATXI) kompaniyasining o'sish potentsialini ko'rsatadi, bunda parametr qiymati 0.00 ga teng. Asosiy xavflar opioidlar ustidan qat'iy nazorat va dori vositalarining xavfsizligiga tegishli bo'lgan ehtimoliy da'volar bilan bog'liq. Shu bilan birga, Avenue Therapeutics (ATXI) dori ishlab chiqarish uchun tashqi cGMP zavodlaridan foydalanish orqali xarajatlarni optimallashtirmoqda. Startap hozirda og'riq terapiyasi va markaziy nerv tizimi (CNS) patologiyalariga yo'naltirilgan dori vositalari uchun FDA tasdig'ini olishga e'tibor qaratmoqda.

ATXI (Avenue Therapeutics, Inc.) Narx-foyda va o‘sish multiplikatori tarixi 04.07.2022dan 29.03.2025gacha

Avenue Therapeutics, Inc. (ATXI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahliliyoti:Avenue Therapeutics, Inc
avenuetx.com seriyali mahsuloti

Foydasi neurologik dori vositalarining so'nggi bosqichdagi sinovlari xarajatlari tufayli cheklangan Avenue Therapeutics (ATXI) uchun ushbu ko'rsatkich kelajakdagi qiymatni baholashning asosiy vositasiga aylanadi. U joriy P/E ko'paytirgichini kutilayotgan foyda o'sishi bilan solishtiradi va qiymat birdan pastga tushganda aktivlarning qadrsizlanganini aniqlaydi. P/E-o'sish nisbatini tahlil qilish investorlarga operatsion leveraj amalga oshirilgunga qadar kirish nuqtasini belgilash imkonini beradi.

Raqobatdosh kompaniyalar

O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven Ltd. BHVN|AMLX (Amylyx) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Precision Medicines)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati prothena.com|Narx-foyda va o‘sish multiplikatori Alector (ALEC)|Narx-foyda va o‘sish multiplikatori ANNX (annexonbio.com)|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori NGNE (Neurogene Inc)|PEG multiplikatori AC Immune S.A. ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati NMRA|SCLX (Scilex Holding Company) - Narx-foyda va o‘sish multiplikatori|TVGN (Tevogen Bio Holdings) - Narxning foydaga va o‘sish sur’atiga nisbati|ACOG (Alpha Cognition Corp) - PEG multiplikatori|Cognition Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori IKT|SAVA (Cassava) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Assertio Holdings, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti COYA|VistaGen Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics OVID|ABOS: PEG multiplikatori|CervoMed Corporation (CRVO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Limited|Narxning foydaga va o‘sish sur’atiga nisbati CLNN|PEG multiplikatori PEPG|JUNS (Jupiter Neurosciences) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Corp RLMD|PEG multiplikatori Annovis Bio Corporation ANVS|gracetx.com - PEG multiplikatori|Firefly Neuroscience, Inc (AIFF) - Narx-foyda va o‘sish multiplikatori|Klotho Neurosciences (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|NeuroSense Therapeutics, Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|RVPH (Reviva Pharmaceuticals Holdings) - PEG multiplikatori|MetaVia Inc (MTVA) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori NRXS|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Helius Medical Technologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati passagebio.com PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|Athira - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ADXN: PEG multiplikatori|ALZN (Alzamend Neuro, Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cyclerion Therapeutics Inc.|PTIX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori KTTA|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati CRGT|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell BCLI|PEG multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG multiplikatori|eliemtx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Intra-Cellular Therapies (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard) - Narxning foydaga va o‘sish sur’atiga nisbati|MRNS (marinuspharma.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharma (NRBO)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori